Patents by Inventor Jeffrey N. Lindquist

Jeffrey N. Lindquist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
    Patent number: 9771581
    Abstract: Provided herein are antisense oligonucleotides that can effectively prevent or decrease c-myc protein expression as well as decrease overall rates of cell proliferation in in vitro and mammalian in vivo models of cell proliferative disorders as well as methods for using the same.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: September 26, 2017
    Assignee: Geron Corporation
    Inventors: Sergei M. Gryaznov, Daria Zielinska, Ronald A. Pruzan, Jeffrey N. Lindquist
  • C-MYC ANTISENSE OLIGONUCLEOTIDES AND METHODS FOR USING THE SAME TO TREAT CELL-PROLIFERATIVE DISORDERS
    Publication number: 20160186173
    Abstract: Provided herein are antisense oligonucleotides that can effectively prevent or decrease c-myc protein expression as well as decrease overall rates of cell proliferation in in vitro and mammalian in vivo models of cell proliferative disorders as well as methods for using the same.
    Type: Application
    Filed: December 2, 2015
    Publication date: June 30, 2016
    Inventors: Sergei M. GRYAZNOV, Daria ZIELINSKA, Ronald A. PRUZAN, Jeffrey N. LINDQUIST
  • C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
    Patent number: 9228189
    Abstract: Provided herein are antisense oligonucleotides that can effectively prevent or decrease c-myc protein expression as well as decrease overall rates of cell proliferation in in vitro and mammalian in vivo models of cell proliferative disorders as well as methods for using the same.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: January 5, 2016
    Assignee: Geron Corporation
    Inventors: Sergei M. Gryaznov, Daria Zielinska, Ronald A. Pruzan, Jeffrey N. Lindquist
  • C-MYC ANTISENSE OLIGONUCLEOTIDES AND METHODS FOR USING THE SAME TO TREAT CELL-PROLIFERATIVE DISORDERS
    Publication number: 20140121261
    Abstract: Provided herein are antisense oligonucleotides that can effectively prevent or decrease c-myc protein expression as well as decrease overall rates of cell proliferation in in vitro and mammalian in vivo models of cell proliferative disorders as well as methods for using the same.
    Type: Application
    Filed: March 14, 2013
    Publication date: May 1, 2014
    Inventors: Sergei M. GRYAZNOV, Daria Zielinska, Ronald A. Pruzan, Jeffrey N. Lindquist